(NaturalNews) After jacking up the price of inhaler medication by 50 percent over the past decade, British multinational pharmaceutical and biotechnology company…
GlaxoSmithKline is pulling a longstanding, life-saving asthma inhaler from the market, putting asthmatic children at risk
Estimated read time
1 min read
